Clinical Trials
Showing 1166 Clinical Trials-
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
Start Date: July 2022 Updated: February 2022
New Haven, Connecticut, USAMDMA
Phase 1
Recruiting
-
A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive Disorder
Start Date: July 2022 Updated: May 2022
Psilocybin
Phase 1|Phase 2
Not yet recruiting
-
Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects
Start Date: July 2022 Updated: April 2018
Boston, Massachusetts, USAKetamine
Not Applicable
Terminated
-
Comparison of Ketamine-propofol Combinations
Start Date: July 2022 Updated: April 2017
Sarıçam, Turkey
Adana, Sarıçam, TurkeyKetamine
Phase 4
Completed
-
Start Date: July 2022 Updated: November 2017
Iran
Tehran, IranKetamine
Phase 4
Completed
-
Start Date: July 2022 Updated: June 2016
Ketamine
Phase 3
Unknown status
-
Spreading Depolarization and Ketamine Suppression
Start Date: July 2022 Updated: October 2017
Albuquerque, New Mexico, USAKetamine
Phase 1
Completed
-
A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Start Date: July 2022 Updated: May 2015
Nottingham, England, United Kingdom
Ruddington, England, United KingdomGHB
Phase 1
Completed
-
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
Start Date: July 2022 Updated: November 2017
New York, New York, USAGHB
Phase 2
Completed
-
Start Date: July 2022 Updated: July 2015
Attiki, Greece
Athens, Attiki, GreeceKetamine
Not Applicable
Completed